Cargando…

Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2(−/−) mouse model of sclerosing cholangitis via immunomodulatory effects

Bile salt export pump (Bsep) (Abcb11)( −/− ) mice are protected from acquired cholestatic injury due to metabolic preconditioning with a hydrophilic bile acid (BA) pool with formation of tetrahydroxylated bile acids (THBAs). We aimed to explore whether loss of Bsep and subsequent elevation of THBA l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuchs, Claudia D., Dixon, Emmanuel D., Hendrikx, Tim, Mlitz, Veronika, Wahlström, Annika, Ståhlman, Marcus, Scharnagl, Hubert, Stojakovic, Tatjana, Binder, Christoph J., Marschall, Hanns‐Ulrich, Trauner, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426398/ https://www.ncbi.nlm.nih.gov/pubmed/35691019 http://dx.doi.org/10.1002/hep4.1998

Ejemplares similares

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(−/−) mice by modulating composition, signalling and excretion of faecal bile acids
por: Fuchs, Claudia Daniela, et al.
Publicado: (2018)

Primary sclerosing cholangitis – The arteriosclerosis of the bile duct?
por: Fickert, Peter, et al.
Publicado: (2007)

Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2(-/-) mouse model of sclerosing cholangitis
por: Fuchs, Claudia D., et al.
Publicado: (2023)

Absence of Bsep/Abcb11 attenuates MCD diet‐induced hepatic steatosis but aggravates inflammation in mice
por: Fuchs, Claudia D., et al.
Publicado: (2020)

Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis
por: Al-Dury, Samer, et al.
Publicado: (2018)

Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis
por: Braadland, Peder Rustøen, et al.
Publicado: (2022)

Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
por: Al-Dury, Samer, et al.
Publicado: (2018)

Cyp3a11 is not essential for the formation of murine bile acids
por: Wahlström, Annika, et al.
Publicado: (2017)

Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy
por: Ovadia, Caroline, et al.
Publicado: (2020)

MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma
por: Voigtländer, Torsten, et al.
Publicado: (2015)

IgG4-Related Sclerosing Cholangitis Involving the Intrahepatic Bile Ducts Diagnosed with Liver Biopsy
por: Thinesen, Malene Theilmann, et al.
Publicado: (2018)

Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis
por: Hov, Johannes R., et al.
Publicado: (2010)

Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis
por: Holm, Matilda, et al.
Publicado: (2022)

Langerhans cell histiocytosis confined to extrahepatic bile duct causing sclerosing cholangitis in child: a case report
por: Murakami, Masakazu, et al.
Publicado: (2020)

A case of eosinophilic cholangitis without bile duct stenosis diagnosed by bile duct biopsy
por: Ukita, Kentaro, et al.
Publicado: (2022)

Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis
por: Tietz-Bogert, Pamela S., et al.
Publicado: (2018)

Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia
por: Pereira, Pedro, et al.
Publicado: (2017)

Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile
por: Vedeld, Hege Marie, et al.
Publicado: (2021)

Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis
por: Grant, Caroline W, et al.
Publicado: (2023)

Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice
por: Abshagen, Kerstin, et al.
Publicado: (2015)

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis
por: Gui, Wenfang, et al.
Publicado: (2023)

Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review
por: Smith, Helen T., et al.
Publicado: (2023)

The role of bile acids in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2021)

Pathogenesis of primary sclerosing cholangitis
por: Pollheimer, Marion J., et al.
Publicado: (2011)

GLP-2 Improves Hepatic Inflammation and Fibrosis in Mdr2(-/-) Mice Via Activation of NR4a1/Nur77 in Hepatic Stellate Cells and Intestinal FXR Signaling
por: Fuchs, Claudia D., et al.
Publicado: (2023)

The Covert Surge: Murine Bile Acid Levels Are Associated With Pruritus in Pediatric Autoimmune Sclerosing Cholangitis
por: Meinel, Katharina, et al.
Publicado: (2022)

Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis
por: Tardelli, Matteo, et al.
Publicado: (2019)

Diagnostic pitfalls and the value of fluorescence in situ hybridization as an adjunct to cytologic evaluation of bile duct brushings in patients with primary sclerosing cholangitis
por: Selvaggi, Suzanne M.
Publicado: (2022)

The protective effect of allopurinol on cholestatic liver injury induced by bile duct ligation.
por: Mun, K. C., et al.
Publicado: (1996)

Primary Amyloidosis Presenting as Common Bile Duct Obstruction With Cholangitis
por: Clough, Jennifer, et al.
Publicado: (2015)

Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
por: Mueller, Michaela, et al.
Publicado: (2015)

Bile Nephropathy in Flucloxacillin-Induced Cholestatic Liver Dysfunction
por: Alnasrallah, Basil, et al.
Publicado: (2016)

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease
por: Tyc, Olaf, et al.
Publicado: (2020)

Bile acid-mediated signaling in cholestatic liver diseases
por: Zeng, Jing, et al.
Publicado: (2023)

Immunoglobulin G4–Related Sclerosing Cholangitis Mimicking Hilar Cholangiocarcinoma Diagnosed With Following Bile Duct Resection: Report of a Case
por: Miki, Atsushi, et al.
Publicado: (2015)

A Cholangioscopy-Based Novel Classification System for the Phenotypic Stratification of Dominant Bile Duct Strictures in Primary Sclerosing Cholangitis—the Edmonton Classification
por: Sandha, Gurpal, et al.
Publicado: (2018)

Early versus delayed laparoscopic common bile duct exploration for common bile duct stone-related nonsevere acute cholangitis
por: Zhu, Bin, et al.
Publicado: (2015)

A Case of Cholangitis Glandularis Proliferans and Cholangiocarcinoma of the Common Bile Duct
por: Richardson, A. J., et al.
Publicado: (1993)

Cholangitis with large common bile duct dilatation caused by choledochal macrolithiasis
por: Joliat, Gaëtan-Romain, et al.
Publicado: (2020)

A rare case of inflammatory polyp in the common bile duct with cholangitis
por: Nakaoka, Kazunori, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_udpm7fcli2c7ji7girvcn3o25j